Muthu Vaduganathan

@mvaduganathan

Cardiologist & Trialist @BrighamWomens @harvardmed | AE @JACCJournals | Podcast #DontMissABeat & #HFinFocus | Disclosures: https://t.co/BmQHCNyLml

9 553Followers

506Following

7 435Posts total

100KViews on collected posts

Against accounts of the same size

5 posts from the last 90 days, next to the under 10K follower range. ordinary reach for its size, weaker reaction than most.

Median views19 292this account3 808median for under 10K

Reach, %201.95%this account249.49%median for under 10K

Engagement, %0.46%this account1.30%median for under 10K

Metric	This account	Median for under 10K	Ratio
Median views per post	19 292	3 808	5.07×
Reach (views ÷ followers)	2.0× audience	2.5× audience	0.81×
Engagement rate	0.46%	1.30%	0.36×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

39.5K2 Sep

40.3K

19.3K

646

1673 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.04%2 Sep

0.48%

0.16%

0.46%

0.60%3 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for under 10K accounts is 1.30%.

What the audience does

Likes54.6%183 in total

Reposts10.1%34 in total

Replies6.0%20 in total

Quotes1.2%4 in total

Bookmarks28.1%94 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

@mvaduganathan It's a wonderful drug All those trials to be interpreted in between All lost the significance by a margin I feel to be pharmacy driven Only issue is gynaecomazia hyperkalemia ( the latter is also common with eplerenone) 167 views · 1 likes · 0 reposts · 0 replies 03 Sep 2026 @mvaduganathan Ahi! Thank you Muthu! And thank you for the time you spent for evidence ! 646 views · 3 likes · 0 reposts · 0 replies 02 Sep 2026 @mvaduganathan lol. only talking about HF. TOPCAT in my view was positive trial due to fishiness in certain regions. SPIRITHF is harder to reconcile since stopped early. CKD is not really a disease and the outcomes from the trials don't necessarily translate to living better or l 19.3K views · 19 likes · 0 reposts · 9 replies 02 Sep 2026 Spironolactone Outcomes RCTs in the Last 20y #TOPCAT (HFpEF) ❓❌ #SPIRITHF (HFpEF) ❓❌ #CLEAR (Post-MI) ❌ #BARACKD (CKD) ❌ #ALCHEMIST (ESKD) ❌ #ACHIEVE (ESKD) ❌ One day we will hopefully have a positive RCT to elevate eminence based medicine to evidence based medicine! 40.3K views · 146 likes · 34 reposts · 11 replies 02 Sep 2026 agree. spironolactone IMO does the same thing. no head to head trial. doubtful will ever be done 39.5K views · 14 likes · 0 reposts · 0 replies 02 Sep 2026